fda statement bpc-157 not approved drug KevinMD.com An FDA advisory committee voted

not for human or veterinary application References Schneider-Helmert D., Schoenenberger G.A

Under Schedule 8, registered community pharmacists are exempt from requiring a manufacturing licence when they extemporaneously compound medicines (excluding biologicals and medicinal cannabis) for a specific patient, provided the goods are supplied from an open, public-facing pharmacy

D., Nottage, J., Hague, D., Kane, F., Bonaccorso, S., Kapur, S

New Zealand Clinical studies have found that when administered, BPC-157 interacts with multiple biological pathways, making it a regenerative medicine that promotes healing and recovery across various tissues and organs